Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review.
Papapetropoulos A, Topouzis S, Alexander SPH, Cortese-Krott M, Kendall DA, Martemyanov KA, Mauro C, Nagercoil N, Panettieri RA Jr, Patel HH, Schulz R, Stefanska B, Stephens GJ, Teixeira MM, Vergnolle N, Wang X, Ferdinandy P.
Papapetropoulos A, et al. Among authors: schulz r.
Br J Pharmacol. 2024 Mar 22. doi: 10.1111/bph.16337. Online ahead of print.
Br J Pharmacol. 2024.
PMID: 38519837
Review.